Events

MDMA hosted over 140 attendees in Palo Alto, CA at our FDA Forum, which continues to grow as the leading policy and regulatory oriented conference designed specifically for medtech regulatory professionals. Attendees networked while learning the latest strategies and insights from industry regulatory experts. Industry leaders held interactive panels focusing on key issues such as biocompatibility, cybersecurity, artificial intelligence, MDUFA implementation, and general strategies for navigating the changing landscape at FDA.

MDMA hosted over 150 attendees at another sold out Reimbursement and Health Policy Conference in Washington, DC. Attendees had the unique opportunity to ask questions from some of the leading experts from the Centers for Medicare and Medicaid Services (CMS) and hear the latest insights from CMS officials, and others, on securing reimbursement for their innovations. Speakers included Tamara Syrek Jensen, Director, CMS Coverage and Analysis Group, Dr. Douglas Kelly, Deputy Center Director for Science, Chief Scientist, CDRH, FDA, Zach Hochstetler, Vice President, Coding and Payment, American Medical Association, Dr. Charles Stemple, former Sr. Medical Director & VP, Health Guidance, Humana and many more.

MDMA's 2024 Executive Forum featured Acting CDRH Director, Dr. Michelle Tarver, CMS Principal Deputy Administrator & COO, Jon Blum, and several other leading industry voices. This conference focused on a range of policy, regulatory, legal, business, investment and security issues facing our industry.

MDMA hosted nearly 200 medtech executives and innovators in DC for our Annual Meeting. Attendees heard from FDA Commissioner Dr. Califf, CDRH Director Shuren, CMS Acting CMO Dora Hughes, Senator Bill Cassidy (LA), Reps. Eshoo (CA), Trahan (MA), Joyce (PA), and many others from government and industry. Attendees also met with the offices of over 45 Members of Congress to discuss issues of importance to medtech innovators.